Zurich Cantonal Bank’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Zurich Cantonal Bank’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-484	Closed	-$9K	–	2573
2017 Q4	$9K	Hold	484	–	–	﹤0.01%	2508
2017 Q3	$6K	Hold	484	–	–	﹤0.01%	2491
2017 Q2	$5K	Hold	484	–	–	﹤0.01%	2503
2017 Q1	$5K	Hold	484	–	–	﹤0.01%	2564
2016 Q4	$7K	Hold	484	–	–	﹤0.01%	2507
2016 Q3	$6K	Hold	484	–	–	﹤0.01%	2515
2016 Q2	$5K	Hold	484	–	–	﹤0.01%	2505
2016 Q1	$5K	Hold	484	–	–	﹤0.01%	2514
2015 Q4	$8K	Hold	484	–	–	﹤0.01%	2464
2015 Q3	$10K	Buy	+484	New	+$11.1K	﹤0.01%	2058

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Zurich Cantonal Bank's SCMP Position: Q1 2018 in Review

Zurich Cantonal Bank sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 484 shares — an estimated $9K sold.

Zurich Cantonal Bank first reported a position in SCMP in Q3 2015 and held it in 10 quarters. The position peaked at $10K in Q3 2015. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Zurich Cantonal Bank reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Zurich Cantonal Bank sold 484 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $9K.
Zurich Cantonal Bank first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2015 and held it in 10 quarters.
Zurich Cantonal Bank's Sucampo Pharmaceuticals, Inc. position peaked at $10K in Q3 2015.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Zurich Cantonal Bank's 13F filing for Q1 2018, filed 3 May 2018.